Gefitinib vs Spironolactone

Gefitinib vs Spironolactone: Overview

This comparison examines the pharmacological differences between Gefitinib and Spironolactone.

Mechanism of Action

Gefitinib: Selective reversible inhibitor of EGFR tyrosine kinase.

Spironolactone: Mineralocorticoid receptor antagonist.

Pharmacokinetics

Half-life: Gefitinib — 48 hours; Spironolactone — 1.4 hours.

Chemical Properties

Molecular Formula: Gefitinib — C22H24ClFN4O3; Spironolactone — C24H32O4S.

Molecular Weight: Gefitinib — 446.9000 g/mol; Spironolactone — 416.5740 g/mol.

Type: Gefitinib — Small molecule; Spironolactone — Small molecule.